Cartography pipeline
Harnessing insights from our ATLAS platform to identify new and compelling targets that will have the greatest impact for patients
PROGRAM
Indication
Target id
Discovery
Preclinical
Clinical
CB21
TCE
CRC
CB02
Esophageal
+ expansion
CB34 x CB48
Solid Tumors
Discovery program
NSCLC (LUAD)
TNBC
Join our team of pioneers
Expand the reach of next-generation cancer therapies by working with us to make them more precise, more effective and more accessible for patients everywhere.